Substrate proton to heme distances in CYP2C9 allelic variants and alterations by the heterotropic activator, dapsone
- 15 July 2008
- journal article
- Published by Elsevier BV in Archives of Biochemistry and Biophysics
- Vol. 475 (2), 175-183
- https://doi.org/10.1016/j.abb.2008.04.034
Abstract
No abstract availableKeywords
This publication has 25 references indexed in Scilit:
- Polymorphic Variants of CYP2C9: Mechanisms Involved in Reduced Catalytic ActivityMolecular Pharmacology, 2007
- CYP2C9 Inhibition: Impact of Probe Selection and Pharmacogenetics on in Vitro Inhibition ProfilesDrug Metabolism and Disposition, 2006
- CYP2C9 Genotype-Dependent Effects on in Vitro Drug-Drug Interactions: Switching of Benzbromarone Effect from Inhibition to Activation in the CYP2C9.3 VariantMolecular Pharmacology, 2005
- The Thermodynamic Landscape of Testosterone Binding to Cytochrome P450 3A4: Ligand Binding and Spin State EquilibriaBiochemistry, 2005
- Effector-Mediated Alteration of Substrate Orientation in Cytochrome P450 2C9Biochemistry, 2004
- Crystal structure of human cytochrome P450 2C9 with bound warfarinNature, 2003
- Polymorphic Variants (CYP2C9*3 and CYP2C9*5) and the F114L Active Site Mutation of CYP2C9: Effect on Atypical Kinetic Metabolism ProfilesDrug Metabolism and Disposition, 2002
- The Substrate Binding Site of Human Liver Cytochrome P450 2C9: An NMR StudyBiochemistry, 1997
- A Model for Human Cytochrome P450 2D6 Based on Homology Modeling and NMR Studies of Substrate BindingBiochemistry, 1996
- Molecular recognition in cytochrome P-450: Mechanism for the control of uncoupling reactionsBiochemistry, 1993